SMARCAL1 and Schimke immuno-osseous dysplasia: This study presents in vitro, in vivo, and human genetic evidence showing that the chromatin regulator SmarcAL1 plays an indispensable role in regulating cellular lipid metabolism, a mechanism linked to the lipid phenotypes seen in SIOD patients.